Rb Capital Management, LLC Bio N Tech Se Transaction History

Rb Capital Management, LLC

  • $385 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 11, 2022
SELL
$126.25 - $231.85 $107,817 - $197,999
-854 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$216.64 - $362.52 $10,182 - $17,038
47 Added 5.82%
854 $220,000
Q3 2021

Nov 12, 2021
BUY
$205.93 - $447.23 $166,185 - $360,914
807 New
807 $220,000

Others Institutions Holding BNTX

# of Institutions
358
Shares Held
38.4M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.2B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Rb Capital Management, LLC Portfolio

Follow Rb Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rb Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email